DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors

por Peyrl, Andreas, Stepien, Natalia, Mayr, Lisa, Azizi, Amedeo, Gojo, Johannes, Baumgartner, Alicia, Hedrich, Cora, Lippolis, Maria Aliotti, Slavc, Irene
Publicado 2022

TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS

por Stepien, Natalia, Mayr, Lisa, Hedrich, Cora, Lippolis, Maria Aliotti, Schned, Hannah, Baumgartner, Alicia, Raimann, Adalbert, Schmook, Maria-Theresa, Traub-Weidinger, Tatjana, Dorfer, Christian, Hartmann, Gabriele, Senfter, Daniel, Madlener, Sibylle, Peyrl, Andreas, Azizi, Amedeo A, Haberler, Christine, Müllauer, Leonhard, Gojo, Johannes
Publicado 2023